Two major hospital groups, Apollo Hospitals and Fortis Healthcare, said they are open to exploring opportunities to import
Amid rising cases of Covid-19, the Odisha government has requested the Centre to provide at least 1.5 million Covishield doses as soon as possible to continue the vaccination drive uninterrupted
A PIL in the Delhi High Court on Tuesday sought a direction to the Centre to waive clinical trials of foreign vaccines
Moderna and vaccine promoter Gavi have announced a firm deal to provide up to 500 million doses for the UN-backed program to ship coronavirus vaccines to needy people in low- and middle-income country
An additional 60 lakh Covid-19 vaccine doses will be received by the states/union territories in the next three days, the central government informed on Monday
In this podcast, we are discussing the process of registration and appointment and all the other things one should keep in mind before taking the jab from and after May 1
South Korea has released a small portion of Iranian funds in its banks for its purchase of medicine and vaccine, a senior businessman said in Tehran
The company is conducting phase 3 efficacy trials on a three-dose regimen of its DNA plasmid technology-based Covid-19 vaccine, which is in its last leg
Could be priced at Rs 600-650/dose for institutional sales
Firms work to secure raw material locally as imports remain a challenge
Govt conducts welcome course correction
States allowed to procure directly from manufacturers; open market supply permitted
Govt okays Rs 4,500 cr upfront payment for 300 mn doses
At an online interaction, he said India prioritised vaccination of its people while describing those as "non-serious" people who questioned why the country was exporting at all
Some good moves but freer pricing needed
Of this list, Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the aforementioned criteria
Bharat Biotech and 3 PSEs to ramp up Covaxin production capacity
Here's a selection of Business Standard opinion pieces for the day
Many vaccine makers in talks with govt as India wants a portfolio of products
Ramping up vaccine availability has become critical